Kobayashi Pharmaceutical KBYPF Stock
Kobayashi Pharmaceutical Price Chart
Kobayashi Pharmaceutical KBYPF Financial and Trading Overview
Kobayashi Pharmaceutical stock price | 37.43 USD |
Previous Close | 55.29 USD |
Open | 55.29 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 55.29 - 55.29 USD |
52 Week Range | 55.29 - 70.34 USD |
Volume | 200 USD |
Avg. Volume | 0 USD |
Market Cap | 5.37B USD |
Beta (5Y Monthly) | 0.306896 |
PE Ratio (TTM) | 28.645079 |
EPS (TTM) | 0.89 USD |
Forward Dividend & Yield | 0.72 (1.29%) |
Ex-Dividend Date | June 29, 2023 |
1y Target Est | N/A |
KBYPF Valuation Measures
Enterprise Value | -96198262784 USD |
Trailing P/E | 28.645079 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.03211311 |
Price/Book (mrq) | 0.021169858 |
Enterprise Value/Revenue | -0.576 |
Enterprise Value/EBITDA | -2.987 |
Trading Information
Kobayashi Pharmaceutical Stock Price History
Beta (5Y Monthly) | 0.306896 |
52-Week Change | -21.40% |
S&P500 52-Week Change | 20.43% |
52 Week High | 70.34 USD |
52 Week Low | 55.29 USD |
50-Day Moving Average | 55.29 USD |
200-Day Moving Average | 56.21 USD |
KBYPF Share Statistics
Avg. Volume (3 month) | 0 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 76.13M |
Float | 40.81M |
Short Ratio | N/A |
% Held by Insiders | 34.52% |
% Held by Institutions | 21.61% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 90 |
Trailing Annual Dividend Yield | 162.79% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.3367 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 12.06% |
Operating Margin (ttm) | 15.99% |
Gross Margin | 55.67% |
EBITDA Margin | 19.27% |
Management Effectiveness
Return on Assets (ttm) | 6.74% |
Return on Equity (ttm) | 10.30% |
Income Statement
Revenue (ttm) | 167.08B USD |
Revenue Per Share (ttm) | 2175.91 USD |
Quarterly Revenue Growth (yoy) | 2.50% |
Gross Profit (ttm) | 92.33B USD |
EBITDA | 32.21B USD |
Net Income Avi to Common (ttm) | 20.16B USD |
Diluted EPS (ttm) | 1.93 |
Quarterly Earnings Growth (yoy) | 3.89% |
Balance Sheet
Total Cash (mrq) | 101.29B USD |
Total Cash Per Share (mrq) | 1330.47 USD |
Total Debt (mrq) | 879M USD |
Total Debt/Equity (mrq) | 0.44 USD |
Current Ratio (mrq) | 3.358 |
Book Value Per Share (mrq) | 2611.496 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Kobayashi Pharmaceutical
Country | United States |
State | N/A |
City | Osaka |
Address | KDX Kobayashi Doshomachi Building |
ZIP | 541-0045 |
Phone | 81 6 6222 0142 |
Website | https://www.kobayashi.co.jp |
Industry | Household & Personal Products |
Sector(s) | Consumer Defensive |
Full Time Employees | 3495 |
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, household products, skincare, and body warmers. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eyebon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods. Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Q&A For Kobayashi Pharmaceutical Stock
What is a current KBYPF stock price?
Kobayashi Pharmaceutical KBYPF stock price today per share is 37.43 USD.
How to purchase Kobayashi Pharmaceutical stock?
You can buy KBYPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kobayashi Pharmaceutical?
The stock symbol or ticker of Kobayashi Pharmaceutical is KBYPF.
Which industry does the Kobayashi Pharmaceutical company belong to?
The Kobayashi Pharmaceutical industry is Household & Personal Products.
How many shares does Kobayashi Pharmaceutical have in circulation?
The max supply of Kobayashi Pharmaceutical shares is 74.34M.
What is Kobayashi Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Kobayashi Pharmaceutical PE Ratio is 42.05618000 now.
What was Kobayashi Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Kobayashi Pharmaceutical EPS is 0.89 USD over the trailing 12 months.
Which sector does the Kobayashi Pharmaceutical company belong to?
The Kobayashi Pharmaceutical sector is Consumer Defensive.